Activation of PPAR<svg style="vertical-align:-3.366pt;width:11.5125px;" id="M1" height="14.2" version="1.1" viewBox="0 0 11.5125 14.2" width="11.5125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,14.2)">
		<g transform="translate(72,-60.64)">
			<text transform="matrix(1,0,0,-1,-71.95,64.04)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝛾</tspan>
			</text>

		</g>
	</g>
</svg> by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats

<table>Serum E2 level in Zucker lean nondiabetic controls (<i>Lean C</i>), Zucker diabetic fatty- (ZDF-) untreated (<i>Diabetic U</i>), and ZDF rats treated with rosiglitazone (<i>Diabetic T</i>). <svg height="11.225" id="M114" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 47.575001 11.225" width="47.575001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.963)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2
q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,18.982,10.963)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,39.347,10.963)"><path d="M137 343l67 33q37 17 63 17q79 0 129.5 -53t50.5 -131q0 -92 -58 -156.5t-147 -64.5t-147 68t-58 182q0 63 17 119t43 95.5t61.5 72t69 52t67.5 31.5q62 22 128 33l6 -32q-56 -11 -108 -35q-149 -71 -184 -231zM227 337q-47 0 -95 -27q-6 -23 -6 -70q0 -93 36 -155.5
t96 -62.5q53 0 78 45.5t25 105.5q0 68 -35 116t-99 48z" id="x36"></path></g>
</svg> per group. Data are expressed as means <svg height="9.5625" id="M115" style="vertical-align:-0.3003pt" version="1.1" viewbox="0 0 10.1 9.5625" width="10.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,9.125)"><path d="M535 290h-212v-206h-58v206h-213v50h213v193h58v-193h212v-50zM535 -22h-483v50h483v-50z" id="xB1"></path></g>
</svg> SE. </table>

PPAR Research

fig5

Figure 5

Figure 5: Activation of PPAR<svg style="vertical-align:-3.366pt;width:11.5125px;" id="M1" height="14.2" version="1.1" viewBox="0 0 11.5125 14.2" width="11.5125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,14.2)">
		<g transform="translate(72,-60.64)">
			<text transform="matrix(1,0,0,-1,-71.95,64.04)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝛾</tspan>
			</text>

		</g>
	</g>
</svg> by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats 

Figure 5 | Activation of PPAR
	
		
			
				𝛾
			

		
	
 by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats 

PPAR Research

Activation of PPAR 𝛾 by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats

Figure 5

Activation of PPAR by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats